| KOTAK MNC FUND
An open-ended equity scheme following Multi-national Companies (MNC) theme
| KOTAK MNC FUND
An open-ended equity scheme following Multi-national Companies (MNC) theme

   

   
Investment Objective

The investment objective of the scheme is to generate long-term capital appreciation from a portfolio that is invested predominantly in equity and equity related securities of multi-national companies (MNC). However, there is no assurance that the objective of the scheme will be achieved.

The investment objective of the scheme is to generate long-term capital appreciation from a portfolio that is invested predominantly in equity and equity related securities of multi-national companies (MNC). However, there is no assurance that the objective of the scheme will be achieved.


Issuer/Instrument
% to Net
Assets

Equity & Equity related
Pharmaceuticals and Biotechnology 17.88
ACUTAAS CHEMICALS LTD 4.11
Sun Pharmaceuticals Industries Ltd. 3.44
Divi s Laboratories Ltd. 2.95
Marksans Pharma Ltd 2.79
VIYASH SCIENTIFIC LTD. 1.41
ANTHEM BIOSCIENCES LTD 1.21
ORCHID PHARMA LTD. 1.09
SAI LIFE SCIENCES LIMITED 0.88
Electrical Equipment 15.51
MTAR TECHNOLOGIES LTD. 4.27
AZAD ENGINEERING LTD 4.09
GE VERNOVA T&D INDIA LIMITED 3.47
Siemens Ltd. 1.98
ABB INDIA LTD 1.70
Auto Components 12.76
SAMVARDHANA MOTHERSON INTERNATIONAL LIMITED 3.10
Bosch Ltd. 2.38
ZF Commercial Vehicle Control Systems India Limited 2.15
Schaeffler India Ltd 2.03
TENNECO CLEAN AIR INDIA LIMITED 1.92
Igarashi Motors India Ltd. 1.18
Food Products 7.31
Britannia Industries Ltd. 3.75
NESTLE INDIA LTD. 3.56
Automobiles 4.99
Maruti Suzuki India Limited 4.99
Capital Markets 4.59
NIPPON LIFE INDIA ASSET MANAGEMENT LTD. 2.44
Aditya Birla Sun Life AMC Ltd 1.82
SBI FUNDS MANAGEMENT LIMITED 0.33
Diversified FMCG 4.26
Hindustan Unilever Ltd. 4.26
Industrial Products 3.89
Cummins India Ltd. 2.21
Grindwell Norton Ltd. 1.60
KSB LTD 0.08
IT - Software 3.80
ORACLE FINANCIAL SERVICES SOFTWARE LTD 3.80
Industrial Manufacturing 3.17
INDO-MIM LTD 3.17
Healthcare Services 3.14
Fortis Healthcare India Ltd 1.73
ASTER DM HEALTHCARE LTD 1.41
Agricultural, Commercial and Construction Vehicles 3.04
ASHOK LEYLAND LTD. 3.04
Beverages 2.65
UNITED SPIRITS LTD. 2.65
Diversified Metals 1.81
Vedanta Ltd. 1.81
Aerospace and Defense 1.63
ROSSELL TECHSYS LTD. 1.63
IT - Services 1.44
TATA TECHNOLOGIES LTD 1.44
Textiles and Apparels 1.41
Garware Technical Fibres Ltd. 1.41
Non - Ferrous Metals 1.32
Hindalco Industries Ltd 1.32
Finance 1.29
APTUS VALUE HOUSING FINANCE 1.29
Consumer Durables 1.11
MIDWEST LTD. 1.11
Fertilizers and Agrochemicals 1.03
P I INDUSTRIES LTD 1.03
Banks 0.97
IndusInd Bank Ltd. 0.97
Equity & Equity related - Total 99.00
Triparty Repo 0.54
Net Current Assets/(Liabilities) 0.46
Grand Total 100.00



Systematic Investment Plan (SIP) If you had invested Rs 10,000 every month
Monthly SIP of Rs 10000 Since Inception 1 Year
Total amount invested (Rs) 2,40,000 1,20,000
Total Value as on August 31, 2026 (Rs) 2,93,962 1,38,021
Scheme Returns (%) 22.35 29.05
Nifty MNC Index Returns (%) 14.46 15.30
Alpha* 7.90 13.74
Nifty MNC Index (TRI) (Rs)# 2,74,531 1,29,666
Nifty 50 (TRI) (Rs)^ 2,40,280 1,18,045
Nifty 50 (TRI) Returns (%) 0.12 -3.01

Scheme Inception : - October 28, 2024. The returns are calculated by XIRR approach assuming investment of ₹10,000/- on the 1st working day of every month. Since Inception returns are assumed to be starting from the inception date of the Scheme and calculated accordingly. XIRR helps in calculating return on investments given an initial and final value and a series of cash inflows and outflows and taking the time of investment into consideration The SIP Performance is for Regular Plan – Growth Option Different plans have different expense structure. # Benchmark; ^ Additional Benchmark. TRI – Total Return Index, In terms of Para no 7.23 of SEBI Master Circular no. HO/24/13/11(1)2026-IMD-POD-1/I/7602/2026 dated March 20, 2026, the performance of the scheme is benchmarked to the Total Return variant (TRI) of the Benchmark Index instead of Price Return Variant (PRI). Alpha is difference of scheme return with benchmark return. *All payouts during the period have been reinvested in the units of the scheme at the then prevailing NAV. Source: ICRA MFI Explorer.

Net Asset Value (NAV)
RegularDirect
Growth Rs12.6610Rs13.0000
IDCW Rs12.6610Rs13.0000
(as on August 31, 2026)

Available Plans/Options

A) Regular Plan B) Direct Plan
Options: Growth and Income Distribution cum capital withdrawal (IDCW) (Payout and Reinvestment)


Fund Manager* Mr. Harsha Upadhyaya,
Mr. Dhananjay Tikariha &
Mr. Abhishek Bisen
BenchmarkNifty MNC Index TRI
Allotment dateOctober 28, 2024
AAUMRs2,300.31 crs
AUMRs2,309.19 crs
Folio count1,07,020

IDCW Frequency

Trustee's Discretion


Ratios
Portfolio Turnover46.99%
$Beta 0.97
$Sharpe ## 0.50
$Standard Deviation 18.17%
^^(P/E) 46.88
^^P/BV 7.65
Source: $ICRA MFI Explorer, ^^Bloomberg

Market Capitalisation*
Large Cap35.07%
Mid Cap 26.16%
Small Cap 37.77%
Debt & Money Market 1.00%

*% of Net Asset

Minimum Investment Amount

Initial & Additional Investment
• Rs100 and any amount thereafter
Systematic Investment Plan (SIP)
• Rs 100 and any amount thereafter

Ideal Investments Horizon

• 5 years & above


Load Structure

Entry Load: Nil. (applicable for all plans)
Exit Load:
• For redemption / switch out within 90 days from the date of allotment: 0.5%
• If units are redeemed or switched out on or after 90 days from the date of allotment - Nil
(With effect from 30th Dec 2024)


Expense Ratio**
Regular Plan: 2.04%
Direct Plan: 0.67%

Data as on 31st August, 2026 unless otherwise specified.

Folio Count data as on 31st July 2026.

Fund


Benchmark : Nifty MNC Index TRI
This product is suitable for investors who are seeking*:
  • Long-term capital growth
  • Investment in portfolio of predominantly in equity and equity related securities of multi-national companies (MNC).

* Investors should consult their financial advisors if in doubt about whether the product is suitable for them.

For latest Riskometer, investors may refer to an addendum issued or updated on website at www.kotakmf.com

## Risk rate assumed to be 5.24% (FBIL Overnight MIBOR rate as on 31st August 2026).**The expense ratio disclosed above represents the Base Expense Ratio (BER), including applicable statutory levies on expenses forming part of the BER, but excludes brokerage, transaction costs and related statutory levies. For Total Expense Ratio including brokerage, transaction cost and related statutory levies please refer our website: https://www.kotakmf.com/Information/TER.
* For Fund Manager experience, please refer 'For Regular Plan' & 'For Direct Plan'
For scheme performance, please refer 'For Regular Plan' & 'For Direct Plan'